Quest Diagnostics (NYSE:DGX) received New York State approval for its Haystack MRD liquid biopsy test, enabling nationwide ...
Medical Device Network on MSN
Quest Diagnostics’ Haystack MRD test secures NYSDOH approval
The clearance gives New York clinicians access to the Haystack MRD assay, which detects residual or recurring solid tumour ...
SECAUCUS, N.J., Oct. 14, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that it has completed its previously announced acquisition of ...
SECAUCUS, N.J. and COLUMBUS, Ohio, July 10, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, and OhioHealth, a nationally recognized ...
Starting in 2019, UnitedHealthcare will use lab data provided by Quest Diagnostics to reduce risk by driving more personalized care. UnitedHealthcare and Quest Diagnostics have established a long-term ...
Quest Diagnostics cited plans to grow its hospital presence among the company's strategic priorities for 2025 via deals like the Corewell Health joint venture, as well as hospital lab outreach ...
Achieving the rigorous laboratory standard broadens access for providers and patients in New York; applies to use of Haystack ...
Just over a week after LabCorp announced it would make test results available through Apple’s Health Record app, another national laboratory is doing the same. Quest Diagnostics announced that its ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. UnitedHealth Group said it is bringing value-based models to lab testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results